Form 4 for TVRD Tvardi Therapeutics, Inc.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-02 · accession 0001209191-23-007170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-03 | 2023-02-02 | TVRD | Posner Christopher | Pres, CEO, Dir | S - Sale | $11.80 | -4,191 | 182.4K | -2% | -$49.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-02 | S | D | 4,191 | $11.80 | 182,370 | D | — | — |